Australia's largest stock trading and investment forum Australia's #1 stock forum

RLF

2.00%

4.9¢ rlf agtech ltd

1. huge market. risk v reward.

First 11 Last

Share
Profile

Follow
lobbo

251 Posts.

15

13/04/24

00:57

Post #: 73325309
Share

Originally posted by edgck: ↑

Yep it is a pity. I also exited.

Some things I didn't like were
1. Too much focus selling in Asia and China which presents some regional risk
2. Hardly any updates on Australia - if the product is so good, why isn't there any update or info on sales in Oz.
3. There was also the misreporting in one of the quarterlies which I picked up (can't remember if it was last year or year before)
4. The seasonal nature of their cashflows where they have one quarter where nearly all cash is spent increasing inventory to sell into for future quarters. This may be due to RLF selling into Asia only. So having an extra region will diversify the cashflow movement.

If we can at least get point 2 sorted with some sales info in Aus, then perhaps things will stabilise.

I'm still watching though. I think at 7c this represents extreme value as it is below the price paid for the pre-ipo holders that had options at 10c.

Didn't mean to make things worse but these I believe are the obvious points why there has been a lack of traction on the share price.
disc: not held

Expand

1. huge market. risk v reward.

RLF Price at posting: 7.0¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BUX

Buxton projects new graphite province discovery at WA Narryer play

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 3 more messages in this thread...

First 11 Last

Add RLF (ASX) to my watchlist

(20min delay)
Last 4.9¢		Change -0.001(2.00%)		Mkt cap ! $11.44M

Open	High	Low	Value	Volume
5.0¢	5.0¢	4.9¢	$10.32K	207.5K

Buyers (Bids)

No.	Vol.	Price($)
1	32000	4.8¢

Sellers (Offers)

Price($)	Vol.	No.
4.9¢	180004	1

View Market Depth

No.	Vol.	Price($)
1	32000	0.048
1	44737	0.046
1	518371	0.045
1	40	0.041
1	30000	0.040

Price($)	Vol.	No.
0.049	180004	1
0.056	59210	1
0.060	330000	1
0.063	27000	1
0.065	44444	1

Last trade - 14.59pm 04/10/2024 (20 minute delay)

RLF (ASX) Chart

1. huge market. risk v reward.

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI reaches close of funding facility for salt-first part of Mardie project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

1. huge market. risk v reward.

Top Stories

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BCI reaches close of funding facility for salt-first part of Mardie project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News